Recombinant FGL1 anticorps (AA 18-312)
Aperçu rapide pour Recombinant FGL1 anticorps (AA 18-312) (ABIN7453972)
Antigène
Voir toutes FGL1 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 18-312
-
Fonction
- Rabbit anti-Hepassocin/FGL1 Recombinant Monoclonal Antibody [BLR210K]
-
Immunogène
- residues 18-312 (full length)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1000 μg/mL
-
Buffer
- Borate Buffered Saline (BBS) pH 8.2 with 0.09 % Sodium Azide, BSA-Free
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Date de péremption
- 12 months
-
-
- FGL1 (Fibrinogen-Like 1 (FGL1))
-
Autre désignation
- Hepassocin/FGL1
-
Sujet
- Background: Hepassocin, also known as Fibrinogen-like 1 (FGL1), is a member of the fibrinogen family whose members share a fibrinogen domain at their C-termini. However, it lacks the platelet-binding site, cross-linking region and thrombin-sensitive site which are necessary for fibrin clot formation. Hepassocin/FGL1 is secreted by hepatocytes and may play a role in the development of hepatocellular carcinomas. Hepassocin/FGL1 is an immune suppressive molecule that inhibits antigen-specific T-cell activation by acting as a major ligand of LAG3 [taken from NCBI Entrez Gene (Gene ID: 2267)].
-
ID gène
- 2267
-
NCBI Accession
- NP_004458
-
UniProt
- Q08830
Antigène
-